ABSTRACT
INTRODUCTION

40
somatic variations in matched RNA-Seq data Sheng et al. [2016] .
Methods to rank and filter candidate sites are often developed using one of two approaches. Early 48 development following the introduction of a new assay are often ad-hoc and may include the use of 49 hard filters or other heuristic(s). These methods are widely recognized as being sub-optimal, but are 50 nevertheless widely applied to new assays. We believe that these methods are used in these instances 51 because: (1) they do not require a strong knowledge of probabilistic models, (2) they are easy to implement 52 in software and (3) domain experts can look at results and contribute suggestions to improve the next 53 iteration of the approach and (4) they enable ranking interesting candidates in the early days of an assay to 54 demonstrate its biological interest. At these stages, it is more important to identify a few strong candidates 55 than to obtain optimal sensitivity and specificity across a wide range of datasets.
56
In contrast, probabilistic methods are developed when an assay becomes popular and more data is 57 produced that requires more sensitive or specific ranking and filtering tools. Developing probabilistic 58 methods relies on a model of the source of errors in an assay. Developing this model for a new assay can 59 be a slow process, but once introduced, probabilistic methods frequently outperform ad-hoc approaches 60 by a wide margin.
61
In this manuscript, we describe a third approach to the ranking and filtering of genomic sites. We 62 aimed for an approach that (1) would be fast to develop and implement for a new assay (2) would provide 63 domain experts with the opportunity to contribute to the development and refinement of the approach,
64
(3) would yield state of the art probabilistic models, (4) can be applied to a wide range of assays and ...
Test Dataset
Deep Learning Model Training use training data to fit neural network parameters. Use validation data to measure performance for early stopping. . A minimum of two samples are necessary to produce a semi-simulated dataset for training. These samples are chosen from data measured from the same individual such that genotypes should match at the majority of sites measured. One sample is arbitrarily assigned the germline role, and the second sample is assigned the somatic role. These samples are provided to the somatic call simulator (whose design can be informed by expert input), which will produce mutated examples using non-mutated examples provided in the input samples (see Methods). Mutations are always added in the sample labeled "somatic". This process yields a training dataset. The same process is repeated with independent pairs of input samples (typically from distinct subjects) to yield a validation and a test set. The training set is used to train a feedforward neural network until performance measured on a small part of the validation set starts to decrease (early stopping). Performance of the fit model can be estimated on the validation set as well as on other benchmark datasets contributed by the community.
To circumvent this problem, we train deep learning models with semi-simulated datasets. Semi-simulated 101 datasets are constructed by simulating signal into samples where no signal is otherwise expected. For instance, in this project, we use two RNA-Seq samples from different types of immune cells from the 103 same subject. Few if any somatic mutations are expected for most sites of the genome in these cells 1 .
104
We simulate somatic variations in one of the two samples by moving bases and associated features of 105 the real data to another genotype (see Material and Methods for details). The resulting semi-simulated 106 dataset should accurately reflect the properties of the real data used as input, and for instance, it is 107 expected to capture characteristics of the library preparation and sequencing assay used to obtain the data.
108
Such characteristics include distribution of base quality for errors and somatic variations, distribution of 109 positions in the reads where variations are observed (i.e., called read index in this study), as well as other 110 features used to train the models.
111
Training probabilistic models 112 An overview of this paradigm is shown in Figure 1 . Briefly, we train deep neural network models using 
Encoding Data as Features
122
The samples depicted in Figure 1 consist of reads aligned to a genome. In order to effectively train a 123 deep learning network, it is necessary to convert alignments to features and labels which are compatible 124 with back-propagation. In this work, we converted alignment data to features using the process shown in for details about feature mapping).
130
The determination of the optimal mapping of read alignment records to features required experimenta-131 tion and was performed in an iterative fashion until we found that the score on the validation set (used Somatic mutation calling for an RNA-Seq assay 139 We applied the process shown in Figure 1 to develop models to rank and filter somatic mutations in 
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Manual Inspection Expected errors:
Unexpected Errors:
Investigate simulator code, correct bugs, retrain model, predict The table is ordered by model probability (that the site is a somatic mutation) and filtered to show only false positive predictions. Manual inspection of such a table helps identify the most extreme errors made by a model. (B) A low signal to noise ratio, as in this case, is an expected source of false positives and may indicate that a model needs further training. (C) This negative example is indistinguishable from a positive example (it looks just like the simulator planted a mutation, when this was not the case). Such errors are possible if the genotype of germline samples differ at some sites (D) This negative example was wrongly classified as a mutation. Upon further investigation of the simulator code, we identified a software bug. During the feature encoding phase, the order of bases was not consistent from sample to sample. Fixing this bug resolved such errors. (D) In a first attempt at simulation, we trained with datasets restricted to have at least 10 counts across the samples at a site. This prevented the model from learning that such sites are more difficult to predict and resulted in over-estimates of model probability. Removing filters from the construction of the training set (to include sites irrespective of their coverage) resolved this issue. The performance of the models developed in this study is summarized in Figure 4 . Each panel shows the 180 received operating curve (ROC) as well as a reliability diagrams Niculescu-Mizil and Caruana [2005] .
181
The reliability diagrams compare the expected true positive rate given by the output model probability, to where we train the model on the same experimental protocol, we find almost optimal model reliability.
184
In Panel B, we test a model trained on RNA-Seq data on the paired exome data. The purpose of this 185 comparison is to determine how transferable a model trained in one assay is to another assay. We find 186 that the model remained predictive for about 40% of the exome sites, but has lower performance on the 187 exome data. The reliability diagram also confirms that the model performs less reliably across assays.
188
Taken together these data suggest that large performance gains can be obtained by training a model to the 189 specific assay that it will be used for, adapting the model to the assay. While we have not measured this The same model trained on Pair Exome data predicts accurately a subset of high-confidence sites (1), with high predicted probability of mutation, but has degraded performance on other sites (2). This is confirmed by the RC, which shows sub-optimal reliability. specific data analysis protocols. 
Training probabilistic methods
210
We have presented a new approach to develop probabilistic models for calling somatic variations in high-211 throughput sequencing data. In contrast to previous studies which have manually designed probabilistic 212 models, we show that it is possible to train probabilistic models using semi-simulated datasets and deep 213 learning methods and that such models adapt to the characteristics of the data produced by specific assays 214 and analysis protocols. Additional validations will be needed to firmly establish that the models trained in this way are predictive 217 on real datasets. Because of regulatory limitations on data sharing of genotype data, which have hampered 218 our ability to obtain suitable validation data, we chose to distribute the software and the models to make it 219 possible for others to conduct independent evaluations on private datasets. We hope to be able to test the 
224
Training for new Assays and Experimental Designs
225
Should our approach perform competitively on real datasets, one of its key advantage will be that training 226 can be performed for arbitrary combinations of new assays, experimental designs, and analysis protocol. trained following simple documented steps using the software that we have developed for this study.
230
Training for a different analysis protocol (e.g., combination of read pre-processing and aligner) can be 231 performed similarly.
232
Training for a new experimental design requires additional feature engineering, which must be 
Semi-simulated datasets
237
Many previous studies have taken advantage of machine learning approaches to train probabilistic methods 238 using annotated real datasets. This work differs in that we create the training sets using real datasets 239 where no difference exists, and plant signal artificially in the real data background. If no datasets can 240 be found with no expected difference, training could be also be performed with a dataset where only a 241 minority of the sites are mutated. This would result in under-estimates of the probability of mutation at a 242 site, but this bias should be small if the proportion of mutated sites in the sample is low with respect to the 243 number of planted mutations introduced in the sample.
244
Of the expected mutation rate 245 We showed that our approach has strong reliability when applied on the same type of assay as that used in 246 the training set. The model outputs the probability that a site is mutated, given the prior distribution of 247 mutated sites in the training set and the reliability diagrams indicate that the forecast probability produced 248 by the model is close to optimal (i.e., lying very close to the diagonal on the reliability diagram). When 249 the proportion of mutated sites in a dataset differs from that used in the training set, as is often the case in 250 practice, it will be necessary to apply Bayes Theorem to adjust for the difference in priors. Doing so will 251 require an estimate of the rate of mutation in the dataset where predictions must be made. Importantly, 252 such adjustments will not change rank order, and for this reason we expect that the model probability 253 output by the software is suitable for ranking somatic mutation in new samples.
254
MATERIAL AND METHODS
255
Subject characteristics and recruitment
256
Data from four subjects was used for developing the RNA-Seq somatic caller. RNA was obtained from 257 sorted cells for control subjects who participated to the CFS/ME study. Any minor subject(s) (<18 
294
• the data indicate that at most two alleles are observed in either sample. This determination is made 295 when the counts from more than 2 genotypes, with genotypes ordered in decreasing count order, 296 have to be summed to reach 90% of all base counts for the site.
297
• the alleles identified by the 2 genotype rule match across samples at the site.
298
In this study, 18% of RNA-seq and 6% of Haloplex records were found to be non-canonical. Canonical few steps. We used a simple heuristic to determine the original genotype, and picked a random "source" 302 base from the two alleles in the genotype. We generated a frequency of mutation, f , from the uniform 303 distribution between 0 and 0.5 (heterozygote site) or 1 (homozygote site), and chose a random "target" 304 genotype from any of the genotypes not marked as source. We then subtracted a proportion f of bases 305 from the source genotype, and added them to the target genotype. Each base retained the same features it 306 was associated with in the source base, namely its read index location, quality score, and forward/reverse needed to produce a fixed-length output so that these outputs could be concatenated consistently into 
352
Finding that it did not introduce training instability, the learning rate was set to the starting value 353 of 1, with SCORE decay (the learning rate was decreased when the loss on the validation set stopped
